Richard E. Maroun - Aug 26, 2021 Form 3 Insider Report for Aadi Bioscience, Inc. (AADI)

Role
Director
Signature
/s/ Neil Desai, as Attorney-in-Fact
Stock symbol
AADI
Transactions as of
Aug 26, 2021
Transactions value $
$0
Form type
3
Date filed
8/31/2021, 08:14 PM
Next filing
Aug 31, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AADI Stock Option (right to buy) Aug 26, 2021 Common Stock 15.9K $2.20 Direct F1
holding AADI Stock Option (right to buy) Aug 26, 2021 Common Stock 7.93K $8.60 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Aadi Subsidiary, Inc. Amended and Restated 2014 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and, thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 28, 2017.
F2 The shares subject to the option became fully vested and exercisable on August 26, 2021.

Remarks:

Exhibit 24 - Power of Attorney